EUVIMEDEUVIMED entdecken
Crossref

Role of AI in drug development: Current status, challenges, opportunities, and future promise

Sheikh Usman Iqbal, Dmitriy Podolskiy, Mona G. Flores, Victoria L. Chiou, Jennifer Sheng, Roberto Araujo, Naveed Afzal, David A. Hall, Ingrid Vasiliu-Feltes, Dipu Patel, Manolis Kellis

Artificial Intelligence in Health · 13.03.2026 · 3 (2) · 025470103

DOI: 10.36922/aih025470103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Intelligence in Health, online erschienen am 13.03.2026. Verfasst von Sheikh Usman Iqbal und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) heralds a transformative shift in drug development, with speed, precision, and predictive power as its core features. Advances in systems-level biology platforms, coupled with substantial investments in generative AI-centric pharma integration, have fostered healthy optimism among stakeholders about identifying new cures through renewed approaches and improved productivity. However, navigating epistemological, ethical, patient safety, and ontological dimensions within research and development (R&D) presents challenges that AI must address to enhance its mainstream adoption and practical utility. Here, multidisciplinary experts discuss key applications of AI across the full continuum of drug development, examine the challenges encountered, and propose solution frameworks. Drug development remains fraught with unknown biology, patient heterogeneity, and perplexing therapeutic risks. Stringent regulatory and compliance guidelines further necessitate that conventional pharma processes, practices, and strategies remain paramount in R&D execution, while guiding the integration of AI in a “value-for-effort,” evidence-based, yet Promethean fashion.

Zitieren

APA

Iqbal, S. U., Podolskiy, D., Flores, M. G., Chiou, V. L., Sheng, J., Araujo, R., Afzal, N., Hall, D. A., Vasiliu-Feltes, I., Patel, D., & Kellis, M. (2026). Role of AI in drug development: Current status, challenges, opportunities, and future promise. Artificial Intelligence in Health, 3(2), 025470103. https://doi.org/10.36922/aih025470103

Vancouver

Iqbal SU, Podolskiy D, Flores MG, Chiou VL, Sheng J, Araujo R, et al. Role of AI in drug development: Current status, challenges, opportunities, and future promise. Artificial Intelligence in Health. 2026;3(2):025470103. doi:10.36922/aih025470103

BibTeX
@article{Iqbal2026,
  author = {Iqbal, Sheikh Usman and Podolskiy, Dmitriy and Flores, Mona G. and Chiou, Victoria L. and Sheng, Jennifer and Araujo, Roberto and Afzal, Naveed and Hall, David A. and Vasiliu-Feltes, Ingrid and Patel, Dipu and Kellis, Manolis},
  title = {Role of AI in drug development: Current status, challenges, opportunities, and future promise},
  journal = {Artificial Intelligence in Health},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {025470103},
  doi = {10.36922/aih025470103}
}
Kostenlos starten →